![]() |
市场调查报告书
商品编码
1541458
2024-2032 年按设备类型、最终用户、配销通路和地区分類的避孕器具市场报告Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2024-2032 |
2023年全球避孕器具市场规模达143亿IMARC Group。人们对计划生育重要性的认识不断提高,意外怀孕的发生率不断上升,以及政府为促进计划生育项目而采取的倡议和资金不断增加,这些都是推动市场发展的一些关键因素。
避孕器具是帮助个人和夫妻预防意外怀孕的重要工具。这些装置透过抑制受精过程有效地防止怀孕。根据设备类型,它们采用各种材料和技术製成。屏障方法(例如保险套和隔膜)可防止精子到达卵子,通常由乳胶、聚氨酯 (PU) 或其他材料製成。荷尔蒙避孕药,例如避孕药、注射和贴片,含有合成激素,可以调节女性的月经週期并防止排卵。另一方面,子宫内避孕器 (IUD) 由铜或塑胶製成,插入子宫以防止怀孕。避孕器具具有许多优点,例如使个人能够自主规划其家庭并就其生殖健康做出明智的选择。它们可供男性和女性使用,提供多种避孕选择。如果正确使用,它们通常是安全有效的,而且许多设备还提供额外的好处,例如预防性传染病 (STI) 或减少月经出血。
全球避孕器具市场由多种因素推动,包括人们对计划生育方法的认识和采用不断提高,以及意外怀孕发生率的增加。此外,政府为促进计划生育计划而采取的措施和资金不断增加,以及性传染感染的盛行率激增,都推动了市场的成长。此外,各种避孕器具(包括口服避孕药、子宫内避孕器、保险套和皮下埋植剂)的供应以及消费者支出能力的增加正在推动市场成长。除此之外,长效可逆避孕药的开发、电子商务领域的扩张以及产品创新的不断增长趋势正在推动市场的成长。与此一致的是,对非荷尔蒙和天然避孕药的需求不断增长以及对女性控制避孕方法的接受度激增也促进了市场的成长。其他因素,例如製造商和医疗保健提供者之间的伙伴关係和合作数量不断增加,以及新兴市场分销网络的扩张,预计将进一步推动市场成长。
The global contraceptive devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.
Contraceptive devices are essential tools that help individuals and couples prevent unintended pregnancies. These devices effectively prevent pregnancy by inhibiting the fertilization process. They are made using various materials and technologies, depending on the type of device. Barrier methods, such as condoms and diaphragms, prevent sperm from reaching the egg and are typically made of latex, polyurethane (PU), or other materials. Hormonal contraceptives, such as birth control pills, injections, and patches contain synthetic hormones that regulate the woman's menstrual cycle and prevent ovulation. On the other hand, intrauterine devices (IUDs) are made of either copper or plastic and are inserted into the uterus to prevent pregnancy. Contraceptive devices offer numerous advantages, such as providing individuals with the autonomy to plan their families and make informed choices about their reproductive health. They can be used by both men and women, offering a wide range of options for contraception. They are generally safe and effective when used correctly, and many devices also provide additional benefits, such as protection against sexually transmitted infections (STIs) or reduced menstrual bleeding.
The global contraceptive devices market is driven by several factors, including the increasing awareness and adoption of family planning methods and the growing incidence of unintended pregnancies. Moreover, the rising government initiatives and funding to promote family planning programs and the surging prevalence of STIs are boosting the market growth. Furthermore, the availability of various contraceptive devices, including oral contraceptives, intrauterine devices, condoms, and subdermal implants, and inflating consumer expenditure power are driving the market growth. Apart from this, the development of long-acting reversible contraceptives, the expansion of the e-commerce sector, and the inflating trend of product innovations are fueling the market growth. In line with this, the increasing demand for non-hormonal and natural contraceptives and the surging acceptance of female-controlled contraceptive methods are also contributing to the market growth. Other factors, such as the growing number of partnerships and collaborations between manufacturers and healthcare providers, as well as the expansion of distribution networks in emerging markets, are expected to propel the market growth further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, end user and distribution channel.
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUDs
Others
The report has provided a detailed breakup and analysis of the contraceptive devices market based on the device type. This includes condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and others. According to the report, condoms accounted for the largest market share.
Male
Female
A detailed breakup and analysis of the contraceptive devices market based on the end user has also been provided in the report. This includes male and female. According to the report, males accounted for the largest market share.
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
A detailed breakup and analysis of the contraceptive devices market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, retail pharmacies accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for contraceptive devices. Some of the factors driving the North America contraceptive devices market included increasing awareness and acceptance, technological advancements, government initiatives, and rising prevalence of STIs.
The report has also provided a comprehensive analysis of the competitive landscape in the global contraceptive devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.